Research Article
Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia
Table 1
Laboratory values of COVID-19 patients and CAP patients.
| Variable | CAP () | COVID-19 () | |
| Age (years) | 50 (32-72) | 53 (41-64) | 0.230 | Gender (M/F) | 80/50 | 152/144 | 0.057 | CD3+ | 936.37 (322.75-1187.5) | 973.11 (596.75-1274) | 0.673 | CD19+ | 248.5 (55.25-285.5) | 184.43 (92-246) | 0.152 | CD3+CD4+ | 426.42 (133.25-580.25) | 579.1 (334-766.5) | <0.001 | CD3+CD8+ | 462.48 (123.75-540.75) | 368.9 (212.75-488) | 0.106 | CD16+CD56+ | 183.98 (64.25-227.5) | 238.59 (107.75-304.25) | 0.007 | 4/8 ratio | 1.47 (0.57-1.73) | 1.81 (1.19-2.21) | 0.015 | CD3+% lym | 67.5 (60.1-77.19) | 67.8 (62.43-74.87) | 0.802 | CD19+% lym | 16.69 (7.41-22.32) | 14 (8.6-17.8) | 0.024 | CD3+CD4+% lym | 31.79 (21.81-39.57) | 40.38 (33.72-46.49) | <0.001 | CD3+CD8+% lym | 31.87 (21.18-39.42) | 25.7 (20-31.4) | <0.001 | CD16+CD56+% lym | 14.6 (7.21-19.4) | 16.75 (9.68-22.2) | 0.038 |
|
|